Cypherpunk Technologies Inc. (CYPH) stock
CYPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.87−0.07 (-3.86%)
Close on Nov 13, 2026Market cap $201.52MP/E –Yield –
Cypherpunk Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Cypherpunk Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.58M, down 95.0% year over year. For fiscal 2025 it was $25.67M, down 55.1% from the year before. The highest annual figure on record is $73.23M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.67M | -55.1% |
| FY2024 | Dec 31, 2024 | $57.21M | -21.9% |
| FY2023 | Dec 31, 2023 | $73.23M | +62.9% |
| FY2022 | Dec 31, 2022 | $44.97M | +39.8% |
| FY2021 | Dec 31, 2021 | $32.16M | +57.5% |
| FY2020 | Dec 31, 2020 | $20.42M | -16.2% |
| FY2019 | Dec 31, 2019 | $24.37M | +11.6% |
| FY2018 | Dec 31, 2018 | $21.83M | -3.0% |
| FY2017 | Dec 31, 2017 | $22.50M | -3.4% |
| FY2016 | Dec 31, 2016 | $23.29M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $197.00K | -98.1% |
| Q1 FY2026 | Mar 31, 2026 | $161.00K | -98.8% |
| Q4 FY2025 | Dec 31, 2025 | $975.00K | -92.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.25M | -91.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.54M | -41.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.91M | +14.3% |
| Q4 FY2024 | Dec 31, 2024 | $13.11M | +12.2% |
| Q3 FY2024 | Sep 30, 2024 | $14.92M | +29.7% |
| Q2 FY2024 | Jun 30, 2024 | $17.89M | +61.1% |
| Q1 FY2024 | Mar 31, 2024 | $11.30M | -71.0% |
| Q4 FY2023 | Dec 31, 2023 | $11.69M | +5.9% |
| Q3 FY2023 | Sep 30, 2023 | $11.50M | -4.9% |
| Q2 FY2023 | Jun 30, 2023 | $11.10M | -20.9% |
| Q1 FY2023 | Mar 31, 2023 | $38.94M | +400.3% |
| Q4 FY2022 | Dec 31, 2022 | $11.03M | +36.7% |
| Q3 FY2022 | Sep 30, 2022 | $12.10M | +20.1% |
| Q2 FY2022 | Jun 30, 2022 | $14.05M | +94.9% |
| Q1 FY2022 | Mar 31, 2022 | $7.78M | +14.4% |
| Q4 FY2021 | Dec 31, 2021 | $8.07M | +58.2% |
| Q3 FY2021 | Sep 30, 2021 | $10.08M | +87.7% |
| Q2 FY2021 | Jun 30, 2021 | $7.21M | +34.7% |
| Q1 FY2021 | Mar 31, 2021 | $6.81M | +47.9% |
| Q4 FY2020 | Dec 31, 2020 | $5.10M | -10.0% |
| Q3 FY2020 | Sep 30, 2020 | $5.37M | -7.0% |
| Q2 FY2020 | Jun 30, 2020 | $5.35M | -12.8% |
| Q1 FY2020 | Mar 31, 2020 | $4.60M | -32.2% |
| Q4 FY2019 | Dec 31, 2019 | $5.67M | -18.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.77M | -10.6% |
| Q2 FY2019 | Jun 30, 2019 | $6.14M | +44.9% |
| Q1 FY2019 | Mar 31, 2019 | $6.79M | +60.5% |
| Q4 FY2018 | Dec 31, 2018 | $6.91M | +56.4% |
| Q3 FY2018 | Sep 30, 2018 | $6.46M | -5.1% |
| Q2 FY2018 | Jun 30, 2018 | $4.23M | -13.3% |
| Q1 FY2018 | Mar 31, 2018 | $4.23M | -33.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.42M | -40.5% |
| Q3 FY2017 | Sep 30, 2017 | $6.80M | +20.2% |
| Q2 FY2017 | Jun 30, 2017 | $4.88M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.42M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.66M | – |
See a number that looks wrong?